State False Claims Summit for Pharmaceutical, Life Sciences Companies and Healthcare Providers

Lena Robins is speaking at the American Conference Institute’s (ACI) “State False Claims Summit for Pharmaceutical, Life Sciences Companies and Healthcare Providers,” May 23 – 24, 2007 in New York, NY.

Topic: Proactively Tracking State Legislative Efforts and Using the Results in Corporate Planning
Date/Time: May 23, 2007 / 11:15 a.m.
Location: The Warwick Hotel, New York, NY

With numerous states contemplating state false claims acts as the result of DRA incentives, companies could be faced with fighting qui tam suits on 50 different state fronts. Knowing what states are enacting legislation is crucial to developing policies and preparing for increased litigation. In this section, you will hear the most up-to-date information on which states are developing state false claims acts and how these potential laws can impact your company.

• Understanding the provisions of recently passed statutes and what action items they require
  
• Determining the status and content of active state proposals
  
• Determining the scope of proposed state acts
  
  
  
  • will the state laws apply only to Medicaid funds?
    
  • will their scope broaden to include Medicare and other programs?
    
  • potentially more draconian state provisions

Speakers:

• Joy Johnson Wilson
  Federal Affairs Counsel and Director of Health Policy, National Conference of State Legislatures
  (Washington, DC)
  
• Barbara L. Zelner
  Counsel, National Association of Medicaid Fraud Control Units
  (Washington, DC)
  
• Lena Robins
  Partner, Foley & Lardner LLP
  (Washington, DC)
  
• John Patrick Oroho (Moderator)
  Principal, Porzio Bromberg & Newman, PC
  (Morristown, NJ)